Call us:
+7 (499) 705-15-45
Email us

News & Events

Clinical Trials Review in Russia (October 2022)
Data review for October 2022 showed a slight decrease in the number of approved drug clinical trials compared to the previous month and more noticeable changes compared to the same period in 2021 - a decrease in the total number of clinical trials by 1.7 times. Details
Clinical Trials Review in Russia (September 2022)
In September 2022, there was a slight increase in the number of approved drug clinical trials compared to the previous month and a sharp decrease in the number of clinical trials compared to the same period in 2021 (more than 2 times). Details
Clinical Trials Review in Russia (August 2022)
In August 2022, a decrease in the total number of approved drug clinical trials was registered compared to the same period in 2021, while at the same time, there were no significant changes in this indicator compared to July 2022. Details
Clinical Trials Review in Russia (July 2022)
In July 2022, there was a decrease in the number of approved drug clinical trials by 23% compared to the previous month and by 40% compared to July 2021. Details
Clinical Trials Review in Russia (June 2022)
Data review of clinical trials for June 2022 showed an increase in the total number of approved drug clinical trials compared to the previous month and almost no change compared to the same period in 2021. Details
Clinical Trials Review in Russia (May 2022)
Data review on clinical trials in May showed a sharp decrease in the number of approved drug clinical trials both compared to the past months of 2022 (especially compared to April of the current year) and compared to most months of 2021. In May 2022, the smallest number of permits for CT was issued in the last 12 months of 2021–2022. (43 trials). At the same time, it should be noted that the minimum indicator for 2021 in terms of the total number of approved clinical trials was also in May 2021 - 29 clinical trials). Details
Clinical Trials Review in Russia (April 2022)
Data review on clinical trials in April 2022 showed a significant increase in the number of approved drug clinical trials both compared to the previous month and compared to the same period in 2021. Details
Clinical Trials Review in Russia (March 2022)
Data review for March 2022 showed a times 1.4 decrease in the number of approved clinical trials of medicines compared to the previous month and a slight increase in the number of approved clinical trials compared to the same period in 2021. Details
Clinical Trials Review in Russia (February 2022)
Data review for February 2022 demonstrated a sharp increase in the number of approved drug clinical trials both compared to the previous month and compared to February 2021. Details
Clinical Trials Review in Russia (2021)
In 2021, 908 medical device clinical trials were approved, which is 19% higher than in 2020 (734 trials) and slightly higher than in 2016 (898 trials), when the largest number of studies have been registered so far per year. Details
Clinical Trials Review in Russia (January 2022)
Data review in January 2022 showed a sharp decrease in the number of approved drug clinical trials compared to the previous month and insignificant changes compared to the first month of 2021. Details
Clinical Trials Review in Russia (November 2021)
Data review on clinical trials in November 2021 shows a slight increase in the number of approved drug clinical trials compared to the previous month and a significant increase compared to the same period in 2020 (in November 2021, 1.75 times more drug clinical trials were approved than in November 2020). Details
Clinical Trials Review in Russia (October 2021)
Data review on clinical trials in October 2021 shows a significant decrease in the number of approved clinical trials compared to the previous month (in September 2021, a historic maximum was registered in the number of clinical trials - 114 initiations), but at the same time, an increase in the number compared to with the same period in 2020. Details
Clinical Trials Review in Russia (September 2021)
Data review on clinical trials in September 2021 demonstrates noticeable increase in the number of approved drug clinical trials compared to the previous month together with the corresponding period of 2020. In September 2021, the maximum number of trials per month was recorded for the entire observation period (2013–2021), which amounted to 114 trials (in previous years, this indicator did not exceed 100 initiations). Details
Clinical Trials Review in Russia (August 2021)
Data review on clinical trials in August 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month together with the corresponding period of 2020. Details
Clinical Trials Review in Russia (July 2021)
Data review on clinical trials in July 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (June 2021)
Data review on clinical trials in June 2021 demonstrates more than a double increase in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (May 2021)
Data review on clinical trials in May 2021 demonstrates strong decrease in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (April 2021)
Data review on clinical trials in April 2021 demonstrates slight decrease in the number of approved drug clinical trials compared to the previous month and the noticeable increase compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (March 2021)
Data review on clinical trials in March 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month and the increase compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (February 2021)
Data review on clinical trials in February 2021 demonstrates slight decrease in the number of approved drug clinical trials compared with the previous month and the increase compared with the corresponding period of 2020. Details
News 1 - 21 of 69